H. Lundbeck A/S is a Danish international pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of pharmaceuticals across the world. Wikipedia
Headquarters: Copenhagen, Denmark
CEO: Charl Van Zyl (Sep 2023–)
President: Charl van Zyl
Founded: 1915
Subsidiaries: Prexton Therapeutics SA, Laboratoire Elaiapharm S.A., Lundbeck Seattle Biopharmaceuticals, and more